David Reyes-Leiva

David Reyes-Leiva

Hospital de la Santa Creu i Sant Pau - Barcelona / Spain
Medical and Health Sciences / Neurology
AD Scientific Index ID: 5617266
Hospital of the Holy Cross and Sant Pau
person_outline David Reyes-Leiva's MOST POPULAR ARTICLES
1-) Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trialJ Diaz-Manera, PS Kishnani, H Kushlaf, S Ladha, T Mozaffar, V Straub, ...The Lancet Neurology 20 (12), 1012-1026, 2021962021
2-) Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double …B Schoser, M Roberts, BJ Byrne, S Sitaraman, H Jiang, P Laforêt, ...The Lancet Neurology 20 (12), 1027-1037, 2021712021
3-) Drug‐refractory myasthenia gravis: Clinical characteristics, treatments, and outcomeE Cortés‐Vicente, R Álvarez‐Velasco, F Pla‐Junca, R Rojas‐Garcia, ...Annals of clinical and translational neurology 9 (2), 122-131, 2022322022
4-) Efficacy and safety of avalglucosidase alfa in patients with late-onset Pompe disease after 97 weeks: a phase 3 randomized clinical trialPS Kishnani, J Diaz-Manera, A Toscano, PR Clemens, S Ladha, ...JAMA neurology 80 (6), 558-567, 2023
5-) Rebound of multiple sclerosis activity after fingolimod withdrawal due to planning pregnancy: analysis of predisposing factorsM Sepúlveda, C Montejo, S Llufriu, N Sola-Valls, D Reyes, ...Multiple sclerosis and related disorders 38, 101483, 2020